Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Cancer

• Publication date

  2013-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejca.2013.02.026PMID 23541563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global cancer statistics

  2011cited by this paper
• Crosstalk in NF-κB signaling pathways

  2011cited by this paper
• Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.

  2011cited by this paper
• High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer

  2011cited by this paper
• Inflammation meets cancer, with NF-κB as the matchmaker

  2011cited by this paper
• Validation of postoperative nomograms in prostate cancer patients with long-term follow-up.

  2011cited by this paper
• An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB

  2010cited by this paper
• Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-κB signalling pathway and prognostic significance in prostate cancer

  2010cited by this paper
• Molecular genetics of prostate cancer: new prospects for old challenges.

  2010cited by this paper
• Nuclear Factor-κB-Mediated Transforming Growth Factor-β-Induced Expression of Vimentin Is an Independent Predictor of Biochemical Recurrence after Radical Prostatectomy

  2009cited by this paper
• Is NF-κB a good target for cancer therapy? Hopes and pitfalls

  2009cited by this paper
• NF‐κB2/p52 enhances androgen‐independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen‐deprivation

  2008cited by this paper
• Clinical significance of p53 alterations in surgically treated prostate cancers

  2008cited by this paper
• TNF/IL‐1/NIK/NF‐κB transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma)

  2008cited by this paper
• The nuclear factor-kappaB pathway controls the progression of prostate cancer to androgen-independent growth.

  2008cited by this paper
• Clinical Significance of Epidermal Growth Factor Receptor Protein Overexpression and Gene Copy Number Gains in Prostate Cancer

  2007cited by this paper
• A phase II trial of bortezomib and prednisone for castration resistant metastatic prostate cancer.

  2007cited by this paper
• Nuclear Localization of Nuclear Factor-κB p65 in Primary Prostate Tumors Is Highly Predictive of Pelvic Lymph Node Metastases

  2006cited by this paper
• Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

  2006cited by this paper
• Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

  2005cited by this paper
• RelA repression of RelB activity induces selective gene activation downstream of TNF receptors.

  2005cited by this paper
• Activation of nuclear factor-κB in human prostate carcinogenesis and association to biochemical relapse

  2005cited by this paper
• Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer In vitro and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate

  2004cited by this paper
• Expression of NF-kappaB in prostate cancer lymph node metastases.

  2004cited by this paper
• Expression of NF‐κB in prostate cancer lymph node metastases

  2004cited by this paper
• Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression.

  2004cited by this paper
• Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence.

  2004cited by this paper
• Nuclear Factor-κB Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer

  2004cited by this paper
• Growth and Survival Mechanisms Associated with Perineural Invasion in Prostate Cancer

  2004cited by this paper
• NF-kappa B nuclear localization and its prognostic significance in prostate cancer.

  2003cited by this paper
• NF‐κB nuclear localization and its prognostic significance in prostate cancer

  2003cited by this paper

• The Antiproliferative Activity of Tatridin A Against Prostate Cancer Cells Is Lost in Acid Medium by Transformation to Desacetyl-β-Cyclopyrethrosin

  2025cites this paper
• Modified Shenqi Dihuang Decoction inhibits prostate cancer metastasis by disrupting TCA cycle energy metabolism via NF-kB/p65-mediated OGDH regulation.

  2025cites this paper
• Erioflorin and Erioflorin Acetate Induce Cell Death in Advanced Prostate Cancer Through ROS Increase and NF-κB Inhibition

  2025cites this paper
• Different Roles of Tocopherols and Tocotrienols in Chemoprevention and Treatment of Prostate Cancer

  2024cites this paper
• Akkermansia muciniphila Metabolite Inosine Inhibits Castration Resistance in Prostate Cancer

  2024cites this paper
• Combinatorial approaches of nanotherapeutics for inflammatory pathway targeted therapy of prostate cancer.

  2022cites this paper
• Overestimation of medical consequences of low-dose exposures to ionizing radiation

  2022cites this paper
• Growth and differentiation factor 15 and NF‐κB expression in benign prostatic biopsies and risk of subsequent prostate cancer detection

  2021cites this paper
• The enhancer rare germline variation rs548071605 contributes to lung cancer development

  2021cites this paper
• A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer

  2021cites this paper
• Expression of ERBB Family Members as Predictive Markers of Prostate Cancer Progression and Mortality

  2021cites this paper
• Translational aspects of Nuclear Factor - kappa B and its modulation by thalidomide on early and late radiation sequelae in urinary bladder dysfunction.

  2020cites this paper
• Pyrimethamine Elicits Antitumor Effects on Prostate Cancer by Inhibiting the p38-NF-κB Pathway

  2020cites this paper
• Integrative Analysis of Regulatory Module Reveals Associations of Microgravity with Dysfunctions of Multi-body Systems and Tumorigenesis

  2020cites this paper
• Significance of Nuclear Factor - Kappa Beta Activation on Prostate Needle Biopsy Samples in the Evaluation of Gleason Score 6 Prostatic Carcinoma Indolence

  2019cites this paper
• Research status and progress of the RNA or protein biomarkers for prostate cancer

  2019cites this paper
• A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores

  2019cites this paper
• Paraffin-embedding lithography and micro-dissected tissue micro-arrays: tools for biological and pharmacological analysis of ex vivo solid tumors.

  2019cites this paper
• Jumping on the Bandwagon: A Review on the Versatile Applications of Gold Nanostructures in Prostate Cancer

  2019cites this paper
• Complex Systems Biology Approach in Connecting PI3K-Akt and NF-κB Pathways in Prostate Cancer

  2019cites this paper
• Research status and progress of the RNA or protein biomarkers for prostate cancer

  2019cites this paper
• Research status and progress of the RNA or protein biomarkers for prostate cancer

  2019cites this paper
• Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network

  2019cites this paper
• Natural forms of vitamin E and metabolites—regulation of cancer cell death and underlying mechanisms

  2018cites this paper
• Subunit-Specific Role of NF-κB in Cancer

  2018cites this paper
• Antiangiogenic compounds: well-established drugs versus emerging natural molecules.

  2018cites this paper
• One-Pot Sequential [3 + 3] Dipolar Cycloaddition of Aldehyde or Ketone and Hydroxylamine with Spirocyclopropyl Oxindole.

  2018cites this paper
• Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer

  2018cites this paper
• Burn-Induced Muscle Wasting: Changes in Muscle Progenitor Cells

  2018cites this paper
• 2018 CUA Abstracts.

  2018cites this paper
• Pelvic Lymph Node Dissection in Prostate Cancer: Indications, Extent and Tailored Approaches

  2017cites this paper
• High Expression of Stromal Cell-Derived Factor 1 (SDF-1) and NF-κB Predicts Poor Prognosis in Cervical Cancer

  2017cites this paper
• Long non-coding RNA GAS5 and ZFAS1 are prognostic markers involved in translation targeted by miR-940 in prostate cancer

  2017cites this paper
• Cycloart-24-ene-26-ol-3-one, a New Cycloartane Isolated from Leaves of Aglaia exima Triggers Tumour Necrosis Factor-Receptor 1-Mediated Caspase-Dependent Apoptosis in Colon Cancer Cell Line

  2016cites this paper
• Prognostic value of toll-like receptor 4 and nuclear factor-κBp65 in oral squamous cell carcinoma patients.

  2016cites this paper
• Cell source determines the immunological impact of biomimetic nanoparticles.

  2016cites this paper
• Examination of CK2α and NF-κB p65 expression in human benign prostatic hyperplasia and prostate cancer tissues

  2016cites this paper
• MP-07 . 01 Rapid prediction of personalized response to chemotherapy using submillimeter ex-vivo biopsy samples on chip

  2016influential citation
• Expression of spermidine/spermine N1‐acetyl transferase (SSAT) in human prostate tissues is related to prostate cancer progression and metastasis

  2015cites this paper
• Magnolol affects cellular growth and proliferation in human prostatecancer cells in vitro

  2015cites this paper
• Protective effects of Acanthopanax vs. Ulinastatin against severe acute pancreatitis-induced brain injury in rats.

  2015cites this paper
• Evaluating DNA damage response (DDR) activation in human prostate cancer

  2015cites this paper
• Prognostic significance of six clinicopathological features for biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis

  2015cites this paper
• Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay

  2015cites this paper
• CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer

  2015cites this paper
• Inhibition of NF-kappa B signaling restores responsiveness of castrate resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor variants expression

  2014cites this paper
• A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease

  2014cites this paper
• Molecular and Cellular Pathobiology AR-Regulated TWEAK-FN 14 Pathway Promotes Prostate Cancer Bone Metastasis

  2014cites this paper
• Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis.

  2014cites this paper
• Regulation of the Prostate Cancer Tumor Microenvironment

  2014cites this paper
• Phytochemicals, polyunsaturated fatty acids and selenium in prostate cancer : - a randomized controlled trial

  2013cites this paper
• Université de Montréal-Thèse numérique

  2013cites this paper